preimplantation-genetic-testing
(2)
Orchid
Orchid is a reproductive genetics company offering the first commercially available whole-genome sequencing test for IVF embryos. Founded by Noor Siddiqui in 2019, Orchid reads more than 99% of an embryo's genome before implantation and screens for over 1,200 monogenic conditions, chromosomal abnormalities, de novo mutations, and polygenic disease risk - so prospective parents can make informed choices before pregnancy begins.
Noor Siddiqui
Noor Siddiqui is the founder and CEO of Orchid Health, a San Francisco-based biotech startup offering whole-genome sequencing for IVF embryos, screening for 1,200+ genetic variants. Motivated by watching her mother lose her sight to retinitis pigmentosa, she dropped out of high school at 17 to become one of the youngest Thiel Fellows, later returned to earn dual CS degrees at Stanford, and then built Orchid with $16.5M in funding from investors including 23andMe founder Anne Wojcicki and Coinbase's Brian Armstrong. She is also the host of the podcast 'Conceivable with Noor.'